10 likes | 117 Views
Supple 3B. Toxicity associated with carboplatin and paclitaxel.
E N D
Supple 3B. Toxicity associated with carboplatin and paclitaxel Abbreviations: MST, median survival time; NR, not reported; NCICTC v. , National Cancer Institute Common Toxicity Criteria Version; TRIBUTE, Tarceva responses inconjunction with paclitaxel and carboplatin; INTACT, ‘Iressa’ NSCLC Trial Assessing Combination Treatment; PD, progression disease; SWOG, South-west Oncology Group; HeCOG, Hellenic Cooperative Oncology Group †The two reference were the same trial. One arm was received four cycles of carboplatin and paclitaxel, whereas one arm was received until disease progression.